• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Eaton Vance Ohio Municipal Income Trust (NQ: EVO )

    3.880 +0.010 (+0.26%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Eaton Vance Ohio Municipal Income Trust

    < Previous 1 2 3 4 5 6 7 8 Next >
    Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
    Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380. 
    Via Benzinga
    WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
      OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates. 
    Via Benzinga
    Sernova, Evotec Join Forces To Develop 'Functional Cure' For Diabetes
    Via Benzinga
    Earnings Scheduled For May 11, 2022
    Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
    Via Benzinga
    Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
      
    Via Benzinga
    11 Health Care Stocks Moving In Wednesday's Pre-Market Session
      Gainers   
    Via Benzinga
    Evotec, Alpine Expand Pact For Commercial Process Development Of Autoimmune Disease Candidate
    Via Benzinga
    Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket
    Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing. 
    Via Benzinga
    Just - Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
    Via ACCESSWIRE
    Just – Evotec Biologics and Alpine Immune Sciences Expand Partnership for Commercial Process Development of ALPN-303
    From Alpine Immune Sciences Inc.
    Via Business Wire
    Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
    An estimated 200 million Americans — more than 60% of the population — suffer from at least one neurological disorder. That includes dementia, strokes, migraines and other diseases or infections that... 
    Via Benzinga
    Evotec SE Reports First Half-year 2022 Results on 11 August 2022
    Via ACCESSWIRE
    The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    This Biotech Company Says That It's Looking To Deliver A Breakthrough In Psychiatric Medicine — What's The Scoop?
    Pasithea Therapeutics Corp. (NASDAQ: KTTA) is a biotech company with a goal of investigating novel drug treatments to provide more effective relief to the estimated 792 million people around the world... 
    Via Benzinga
    Evotec SE Reports Results of Annual General Meeting 2022
    HAMBURG, GERMANY / ACCESSWIRE / June 22, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) today announced that its shareholders approved all proposals the... 
    From Evotec SE
    Via AccessWire
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Exscientia -Evotec Cancer Therapy Shows Encouraging Action In Healthy Volunteers
    Via Benzinga
    Evotec Enters a Drug Discovery Collaboration with Janssen
    HAMBURG, GERMANY / ACCESSWIRE / June 14, 2022 / Evotec SE (FRA:EVT)(MDAX/TecDAX)(ISIN:DE0005664809)(NASDAQ:EVO) announced today that the Company has entered a drug discovery collaboration with Janssen... 
    From Evotec SE
    Via AccessWire
    Evotec Adds Cell Therapy Manufacturing Facility with Acquisition of Rigenerand
    CELLS PLATFORM INTEGRATES INNOVATIVE OFF-THE-SHELF IPSC CELL THERAPY DISCOVERY WITH DEVELOPMENT AND MANUFACTURING 
    From Evotec AE
    Via AccessWire
    The Daily Biotech Pulse: Valneva's COVID-19 Vaccine Filing Accepted By EMA, Enanta's RSV Candidate Fails, Orphan Drug Tag For Mersana's Gastric Cancer Candidate
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
    HAMBURG, GERMANY and BARCELONA, SPAIN / ACCESSWIRE / May 19, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) and Almirall S.A. (ALM), a global... 
    From Evotec AG
    Via AccessWire
    The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    99 Biggest Movers From Yesterday
    Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company. 
    Via Benzinga
    52 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Trecora Resources (NYSE: TREC) shares jumped 26.6% to $9.56 as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247... 
    Via Benzinga
    The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Good morning and welcome back for another busy day of trading as we cover the biggest pre-market stock movers for Wednesday! 
    Via InvestorPlace
    34 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Embark Technology, Inc. (NASDAQ: EMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share. 
    Via Benzinga
    Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership
    HAMBURG, GERMANY / ACCESSWIRE / May 10, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces today that the Company has extended and... 
    From Evotec AG
    Via AccessWire
    Evotec and Bristol Myers Squibb Extend and Expand Strategic Partnership in Protein Degradation
    - 8-YEAR EXTENSION AND EXPANSION OF COLLABORATION TO DEVELOP PIPELINE OF MOLECULAR GLUE DEGRADERS - COLLABORATION LEVERAGES EVOTEC'S PROPRIETARY EVO PANOMICS AND EVO PANHUNTER PLATFORMS COVERING... 
    From Evotec AG
    Via AccessWire
    Evotec SE to Announce Results for the First Quarter 2022 on 11 May 2022
    Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. 
    From Evotec AG
    Via AccessWire
    < Previous 1 2 3 4 5 6 7 8 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.